Endocrine

Endocrine

Purpose:
The Endocrine Programme is available as part of a comprehensive suite of programmes to assess and monitor the performance of the routine Clinical Biochemistry laboratory’s repertoire of core tests used for the diagnosis and monitoring of disease. The panel of tests in this programme covers a range of hormones used to assess endocrine diseases such as adrenocortical disorders (cortisol), thyroid disease (FT4, FT3, TSH), pituitary function (LH, FSH, prolactin), and gonadal disorders (oestrogen, progesterone, testosterone, and SHBG). These tests are often undertaken on routine Immunoassay platforms.

Scope:
Four levels of liquid human serum samples are distributed monthly, with a minimum of 48 samples distributed over the year covering a wide clinically relevant range for steroid, thyroid function and fertility profiles. The material is prepared from endogenous samples donated by both patients and healthy volunteers, with the addition of purified source of T4, T3, TSH, oestradiol, progesterone and cortisol to enhance the pathological range for certain samples. Each batch consists of up to 56 different samples distributed on more than one occasions over a 2-year period. ID-LC-MS/MS or ID GCMS reference target values are available for cortisol, progesterone and testosterone for all samples. This allows for the long term assessment of laboratory and method performance, including trueness, linearity, bias, within and between batch imprecision.

Challenging samples are distributed to assess the performance at clinical decision points as well as effects of interferences such as turbidity, icterus, heterophilic antibodies along with an ongoing programme of interpretative exercises. Macroprolactin exercises are conducted periodically to assess current laboratory practice in Macroprolactin investigation.


Key Features:

  • Commutable, endogenous samples including those that challenge immunoassays such as sample with Macroprolactin and antibody interferences, and samples that mimic ovarian hyperstimulation syndrome.
  • Liquid human serum samples requiring no prior preparation.
  • Single donor samples are used wherever possible to minimise any matrix effects. Programme assesses both laboratory and method performance, including bias, within and between batch imprecision.
  • Trueness is also assessed for Testosterone, Cortisol and Progesterone using high metrological order Reference measurement systems.
  • Includes Calculated parameters.
  • Scoring based on Milan Model 3 performance specification.

Frequency:
Monthly
Samples:
4 x 1.8mL
Material:
Off the clot human serum
Endocrine Prorgamme
AnalyteApprox. Range Covered
Cortisol 60 - 1450 nmol/L
Progesterone 1.0 - 100nmol/L
Oestradiol 37 - 16000 pmol/L
Testosterone 0.1 - 60 nmol/L
Free Testosterone0 - 2mol/L
SHBG20 - 100nmol/L
FAI0 - 150%
DHEA-S0 - 100µmol/L
T4 64 - 280 nmol/L
T3 1.5 - 12 nmol/L
FT4 8 - 50 pmol/L
FT3 3.0 - 40 pmol/L
TSH 0.1 - 55mU/L
LH 2 - 80 IU/L
FSH 0.8 - 100 IU/L
Prolactin48 - 800 mU/L

Related Documents

Accreditation

UKAS Proficiency Testing 4301UKAS Calibration 4301


EQA Programme Enquiry

    Forename / First Name*

    Surname / Family Name*

    Email*

    Client type*

    Weqas Participant / Lab Code (if known)

    Organisation*

    What EQA programme are you interested in?

    Message

    *required